首页 > 最新文献

Journal of Hepatology最新文献

英文 中文
Reply to: “Reassessing the causal association between frailty and chronic liver disease: Evidence from genetic analyses” 答复"重新评估虚弱与慢性肝病之间的因果关系:来自基因分析的证据"
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-07 DOI: 10.1016/j.jhep.2024.10.034
Qi Zhong, Hao-Wen Chen, Shun Zhang, Ji-Yuan Zhou, Xian-Bo Wu

Section snippets

Data availability statement

GWAS summary statistics for frailty are available for download from the MRC-IEU GWAS database (https://gwas.mrcieu.ac.uk/). Similarly, GWAS summary statistics for liver disease can be accessed through the FinnGen consortium (https://r11.finngen.fi/).

Authors’ contributions

QZ, H-WC, and SZ drafted the manuscript and performed the main MR analyses. X-BW and J-YZ revised the manuscript. All authors reviewed and approved the final manuscript.

Financial support

This study was supported by the National Natural Science Foundation of China [grant numbers 82173607, 82173619], and the Guangdong Basic and Applied Basic Research Foundation [grant numbers 2021A1515011684, 2024A1515011969]. The funders had no role in study design, data collection or analysis, data interpretation, manuscript writing, or decision to submit the paper for publication.

Declaration of Competing Interest

The authors of this study declare that they do not have any conflict of interest.

Acknowledgements

GWAS summary statistics for frailty are available for download from the MRC-IEU GWAS database (https://gwas.mrcieu.ac.uk/). Similarly, GWAS summary statistics for liver disease can be accessed through the FinnGen consortium (https://r11.finngen.fi/).
章节片段数据提供声明虚弱的GWAS汇总统计数据可从MRC-EU GWAS数据库(https://gwas.mrcieu.ac.uk/)下载。同样,肝脏疾病的 GWAS 统计摘要也可通过 FinnGen 财团获取 (https://r11.finngen.fi/)。作者贡献QZ、H-WC 和 SZ 起草了稿件并进行了主要的 MR 分析。X-BW 和 J-YZ 修改了手稿。本研究得到了国家自然科学基金[基金号:82173607、82173619]和广东省基础与应用基础研究基金[基金号:2021A1515011684、2024A1515011969]的资助。资助者在研究设计、数据收集或分析、数据解释、稿件撰写以及决定是否将论文提交发表等方面均未发挥作用。利益冲突声明本研究的作者声明他们没有任何利益冲突。致谢虚弱的GWAS汇总统计数据可从MRC-IEU GWAS数据库(https://gwas.mrcieu.ac.uk/)下载。同样,肝病的 GWAS 统计摘要也可通过 FinnGen 财团 (https://r11.finngen.fi/) 访问。
{"title":"Reply to: “Reassessing the causal association between frailty and chronic liver disease: Evidence from genetic analyses”","authors":"Qi Zhong, Hao-Wen Chen, Shun Zhang, Ji-Yuan Zhou, Xian-Bo Wu","doi":"10.1016/j.jhep.2024.10.034","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.034","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Data availability statement</h2>GWAS summary statistics for frailty are available for download from the MRC-IEU GWAS database (<span><span>https://gwas.mrcieu.ac.uk/</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>). Similarly, GWAS summary statistics for liver disease can be accessed through the FinnGen consortium (<span><span>https://r11.finngen.fi/</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>).</section></section><section><section><h2>Authors’ contributions</h2>QZ, H-WC, and SZ drafted the manuscript and performed the main MR analyses. X-BW and J-YZ revised the manuscript. All authors reviewed and approved the final manuscript.</section></section><section><section><h2>Financial support</h2>This study was supported by the National Natural Science Foundation of China [grant numbers 82173607, 82173619], and the Guangdong Basic and Applied Basic Research Foundation [grant numbers 2021A1515011684, 2024A1515011969]. The funders had no role in study design, data collection or analysis, data interpretation, manuscript writing, or decision to submit the paper for publication.</section></section><section><section><h2>Declaration of Competing Interest</h2>The authors of this study declare that they do not have any conflict of interest.</section></section><section><section><h2>Acknowledgements</h2>GWAS summary statistics for frailty are available for download from the MRC-IEU GWAS database (<span><span>https://gwas.mrcieu.ac.uk/</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>). Similarly, GWAS summary statistics for liver disease can be accessed through the FinnGen consortium (<span><span>https://r11.finngen.fi/</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>).</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to: “From mice to humans: Unravelling the genetic levers of NASH” [J Hepatol (2020) 749-751] 更正:"从小鼠到人类:揭示 NASH 的遗传杠杆" [J Hepatol (2020) 749-751] 更正
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-07 DOI: 10.1016/j.jhep.2024.10.002
Wajahat Zafar Mehal
It has come to our attention that the following text should have been included in the ‘Financial support’ section of this article: “Dr. Mehal has an appointment at the West Haven VA Medical Center and this work was supported by a US Department of Veterans Office of Research & Development with grant BX003259-05A1”. We apologise for any inconvenience caused.
我们注意到,本文的 "财务支持 "部分应包含以下文字:"Mehal 博士在西黑文退伍军人医疗中心(West Haven VA Medical Center)任职,这项工作得到了美国退伍军人部研究与发展办公室(US Department of Veterans Office of Research & Development)BX003259-05A1 号基金的支持。我们对由此造成的不便深表歉意。
{"title":"Corrigendum to: “From mice to humans: Unravelling the genetic levers of NASH” [J Hepatol (2020) 749-751]","authors":"Wajahat Zafar Mehal","doi":"10.1016/j.jhep.2024.10.002","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.002","url":null,"abstract":"It has come to our attention that the following text should have been included in the ‘Financial support’ section of this article: “Dr. Mehal has an appointment at the West Haven VA Medical Center and this work was supported by a US Department of Veterans Office of Research &amp; Development with grant BX003259-05A1”. We apologise for any inconvenience caused.","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rethinking Methodology and Data Integrity in Mendelian Randomization: Insights from Air Pollution and MASLD Research 反思孟德尔随机化的方法和数据完整性:空气污染和 MASLD 研究的启示
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-06 DOI: 10.1016/j.jhep.2024.10.040
Junhao Chen, Haifeng Wang, Shi Fu

Section snippets

Authors’ contributions

Junhao Chen: conceptualization and manuscript draft. Haifeng Wang: supporting role in revision for important intellectual content. Shi Fu: critical revision for important intellectual content, final approval.

Financial support

None

Declaration of Competing Interest

The authors of this study declare that they do not have any conflict of interest.
章节片段作者贡献陈俊豪:构思和手稿起草。王海峰:对重要知识内容的修改起支持作用。财务支持无竞争利益声明本研究的作者声明他们没有任何利益冲突。
{"title":"Rethinking Methodology and Data Integrity in Mendelian Randomization: Insights from Air Pollution and MASLD Research","authors":"Junhao Chen, Haifeng Wang, Shi Fu","doi":"10.1016/j.jhep.2024.10.040","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.040","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Authors’ contributions</h2>Junhao Chen: conceptualization and manuscript draft. Haifeng Wang: supporting role in revision for important intellectual content. Shi Fu: critical revision for important intellectual content, final approval.</section></section><section><section><h2>Financial support</h2>None</section></section><section><section><h2>Declaration of Competing Interest</h2>The authors of this study declare that they do not have any conflict of interest.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142588319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: “Prediction of HBsAg loss after cessation of entecavir therapy” 答复"恩替卡韦治疗停止后 HBsAg 消失的预测"
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-06 DOI: 10.1016/j.jhep.2024.10.041
Rex Wan-Hin Hui, Lung-Yi Mak, Man-Fung Yuen

Section snippets

AUTHOR CONTRIBUTIONS

RWH Hui was involved in manuscript design and drafting of manuscript. LY Mak was involved in critical revision of manuscript. MF Yuen was involved in critical revision of manuscript and overall study supervision. The authors declare that they have participated in the preparation of the manuscript and have seen and approved the final version.

DISCLOSURES/ CONFLICT OF INTEREST STATEMENT

MF Yuen is an advisory board member and/or received research funding from AbbVie, Arbutus Biopharma, Assembly Biosciences, Bristol Myer Squibb, Dicerna Pharmaceuticals, GlaxoSmithKline, Gilead Sciences, Janssen, Merck Sharp and Dohme, Clear B Therapeutics, Springbank Pharmaceuticals; and received research funding from Arrowhead Pharmaceuticals, Fujirebio Incorporation and Sysmex Corporation. The remaining authors have no conflict of interests.

DATA AVAILABILITY STATEMENT

The data from this study is available from the corresponding author upon reasonable request.

Funding

Innovative Research Fund of the State Key Laboratory of Liver Research, The University of Hong Kong (ref. no.: SKLLR/IRF/2018/07) and the S. K. Yee Medical Foundation Grant (ref. no.: 2141213). The funders had no involvement in study design, data collection/ analysis/ interpretation, writing of the manuscript or decision to submit the article for publication.
章节片段作者贡献RWH Hui参与了手稿的设计和起草。LY Mak 参与了稿件的重要修改。MF Yuen 参与了稿件的关键修改和整个研究的监督。作者声明:他们参与了手稿的准备工作,并审阅和批准了最终版本。声明/利益冲突声明MF Yuen 是艾伯维、Arbutus Biopharma、Assembly Biosciences、Bristol Myer Squibb、Dicerna Pharmaceuticals、葛兰素史克、吉利德科学、杨森、默克夏普和多美、Clear B Therapeutics、Springbank Pharmaceuticals 的顾问委员会成员和/或接受其研究资助;并接受 Arrowhead Pharmaceuticals、Fujirebio Incorporation 和 Sysmex Corporation 的研究资助。其余作者无利益冲突。数据提供声明本研究的数据可向相应作者索取。资助者没有参与研究设计、数据收集/分析/解释、手稿撰写或决定将文章提交发表。
{"title":"Reply to: “Prediction of HBsAg loss after cessation of entecavir therapy”","authors":"Rex Wan-Hin Hui, Lung-Yi Mak, Man-Fung Yuen","doi":"10.1016/j.jhep.2024.10.041","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.041","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>AUTHOR CONTRIBUTIONS</h2>RWH Hui was involved in manuscript design and drafting of manuscript. LY Mak was involved in critical revision of manuscript. MF Yuen was involved in critical revision of manuscript and overall study supervision. The authors declare that they have participated in the preparation of the manuscript and have seen and approved the final version.</section></section><section><section><h2>DISCLOSURES/ CONFLICT OF INTEREST STATEMENT</h2>MF Yuen is an advisory board member and/or received research funding from AbbVie, Arbutus Biopharma, Assembly Biosciences, Bristol Myer Squibb, Dicerna Pharmaceuticals, GlaxoSmithKline, Gilead Sciences, Janssen, Merck Sharp and Dohme, Clear B Therapeutics, Springbank Pharmaceuticals; and received research funding from Arrowhead Pharmaceuticals, Fujirebio Incorporation and Sysmex Corporation. The remaining authors have no conflict of interests.</section></section><section><section><h2>DATA AVAILABILITY STATEMENT</h2>The data from this study is available from the corresponding author upon reasonable request.</section></section><section><section><h2>Funding</h2>Innovative Research Fund of the State Key Laboratory of Liver Research, The University of Hong Kong (ref. no.: SKLLR/IRF/2018/07) and the S. K. Yee Medical Foundation Grant (ref. no.: 2141213). The funders had no involvement in study design, data collection/ analysis/ interpretation, writing of the manuscript or decision to submit the article for publication.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142588329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to make a decision for the use of plasma exchange in patients with acute liver failure? 如何决定对急性肝衰竭患者进行血浆置换?
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-06 DOI: 10.1016/j.jhep.2024.10.038
Xiang-Yu Han, Hui-ru Qi

Section snippets

Financial support

The author received no financial support to produce this manuscript.

Authors’ contributions

Xiang-Yu Han: manuscript writing; Hui-ru Qi: critical revision

Declaration of Competing Interest

The author declare no conflicts of interest.
作者的贡献韩湘玉:手稿撰写;齐慧茹:重要修改竞争利益声明作者声明无利益冲突。
{"title":"How to make a decision for the use of plasma exchange in patients with acute liver failure?","authors":"Xiang-Yu Han, Hui-ru Qi","doi":"10.1016/j.jhep.2024.10.038","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.038","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Financial support</h2>The author received no financial support to produce this manuscript.</section></section><section><section><h2>Authors’ contributions</h2>Xiang-Yu Han: manuscript writing; Hui-ru Qi: critical revision</section></section><section><section><h2>Declaration of Competing Interest</h2>The author declare no conflicts of interest.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142588320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma exchange in Acute liver failure: The jury is still out! 急性肝衰竭的血浆置换:尚无定论!
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-06 DOI: 10.1016/j.jhep.2024.10.037
Sagnik Biswas, Shekhar Swaroop

Section snippets

Financial disclosures funding

None

Conflicts of interest COI

The authors declare no conflicts of interest

Authors contributions author-disclosure

SB and SS wrote the initial draft. S revised the paper. All authors approved the final manuscript.
章节片段财务披露资金无利益冲突作者声明无利益冲突作者供稿作者披露SB和SS撰写了初稿。S 修改了论文。所有作者都批准了最终稿。
{"title":"Plasma exchange in Acute liver failure: The jury is still out!","authors":"Sagnik Biswas, Shekhar Swaroop","doi":"10.1016/j.jhep.2024.10.037","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.037","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Financial disclosures funding</h2>None</section></section><section><section><h2>Conflicts of interest COI</h2>The authors declare no conflicts of interest</section></section><section><section><h2>Authors contributions author-disclosure</h2>SB and SS wrote the initial draft. S revised the paper. All authors approved the final manuscript.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: “Community health strategies for chronic hepatitis B: Advancing care with the ALT/qHBsAg ratio” 答复"慢性乙型肝炎的社区健康策略:利用谷丙转氨酶/qHBsAg 比值促进护理"
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-06 DOI: 10.1016/j.jhep.2024.10.042
Rex Wan-Hin Hui, Lung-Yi Mak, Man-Fung Yuen

Section snippets

Author Contributions

RWH Hui was involved in manuscript design and drafting of manuscript. LY Mak was involved in critical revision of manuscript. MF Yuen was involved in critical revision of manuscript and overall study supervision. The authors declare that they have participated in the preparation of the manuscript and have seen and approved the final version.

Disclosures/ Conflict Of Interest Statement

MF Yuen is an advisory board member and/or received research funding from AbbVie, Arbutus Biopharma, Assembly Biosciences, Bristol Myer Squibb, Dicerna Pharmaceuticals, GlaxoSmithKline, Gilead Sciences, Janssen, Merck Sharp and Dohme, Clear B Therapeutics, Springbank Pharmaceuticals; and received research funding from Arrowhead Pharmaceuticals, Fujirebio Incorporation and Sysmex Corporation. The remaining authors have no conflict of interests.

Data Availability Statement

The data from this study is available from the corresponding author upon reasonable request.

Funding

Innovative Research Fund of the State Key Laboratory of Liver Research, The University of Hong Kong (ref. no.: SKLLR/IRF/2018/07) and the S. K. Yee Medical Foundation Grant (ref. no.: 2141213). The funders had no involvement in study design, data collection/ analysis/ interpretation, writing of the manuscript or decision to submit the article for publication.
部分片段作者贡献RWH Hui参与了手稿的设计和起草。LY Mak 参与了稿件的重要修改。MF Yuen 参与了稿件的重要修改和整个研究的监督。作者声明:他们参与了稿件的撰写,并审阅和批准了最终版本。披露/利益冲突声明袁中锋是艾伯维、Arbutus Biopharma、Assembly Biosciences、Bristol Myer Squibb、Dicerna Pharmaceuticals、葛兰素史克、吉利德科学、杨森、默沙东、Clear B Therapeutics、Springbank Pharmaceuticals 的顾问委员会成员和/或接受其研究资助;并接受 Arrowhead Pharmaceuticals、Fujirebio Incorporation 和 Sysmex Corporation 的研究资助。其余作者无利益冲突。数据提供声明本研究的数据可向通讯作者索取。基金资助香港大学肝脏研究国家重点实验室创新研究基金(编号:SKLLR/IRF/2018/07)和余兆麒医学基金会资助(编号:2141213)。资助者没有参与研究设计、数据收集/分析/解释、手稿撰写或决定将文章提交发表。
{"title":"Reply to: “Community health strategies for chronic hepatitis B: Advancing care with the ALT/qHBsAg ratio”","authors":"Rex Wan-Hin Hui, Lung-Yi Mak, Man-Fung Yuen","doi":"10.1016/j.jhep.2024.10.042","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.042","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Author Contributions</h2>RWH Hui was involved in manuscript design and drafting of manuscript. LY Mak was involved in critical revision of manuscript. MF Yuen was involved in critical revision of manuscript and overall study supervision. The authors declare that they have participated in the preparation of the manuscript and have seen and approved the final version.</section></section><section><section><h2>Disclosures/ Conflict Of Interest Statement</h2>MF Yuen is an advisory board member and/or received research funding from AbbVie, Arbutus Biopharma, Assembly Biosciences, Bristol Myer Squibb, Dicerna Pharmaceuticals, GlaxoSmithKline, Gilead Sciences, Janssen, Merck Sharp and Dohme, Clear B Therapeutics, Springbank Pharmaceuticals; and received research funding from Arrowhead Pharmaceuticals, Fujirebio Incorporation and Sysmex Corporation. The remaining authors have no conflict of interests.</section></section><section><section><h2>Data Availability Statement</h2>The data from this study is available from the corresponding author upon reasonable request.</section></section><section><section><h2>Funding</h2>Innovative Research Fund of the State Key Laboratory of Liver Research, The University of Hong Kong (ref. no.: SKLLR/IRF/2018/07) and the S. K. Yee Medical Foundation Grant (ref. no.: 2141213). The funders had no involvement in study design, data collection/ analysis/ interpretation, writing of the manuscript or decision to submit the article for publication.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142588333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Memoriam: Prof. Francesco Salerno 悼念弗朗切斯科-萨勒诺教授
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-06 DOI: 10.1016/j.jhep.2024.09.036
Vincenzo La Mura, Mauro Bernardi, Paolo Angeli
Professor Francesco Salerno was a brilliant man who dedicated his life to helping patients with advanced chronic liver diseases and who was internationally renowned for his studies on the pathophysiology of cirrhosis and its complications, as well as the management of patients with ascites, renal dysfunction and bacterial infections. He contributed to the foundation of key international groups such as the International Club of Ascites, the CLIF consortium, and the Baveno group.
弗朗切斯科-萨勒诺教授是一位杰出的人,他毕生致力于帮助晚期慢性肝病患者,在肝硬化病理生理学及其并发症的研究,以及腹水、肾功能障碍和细菌感染患者的治疗方面享誉国际。他为国际腹水俱乐部(International Club of Ascites)、CLIF 联合会和巴韦诺小组等重要国际组织的成立做出了贡献。
{"title":"In Memoriam: Prof. Francesco Salerno","authors":"Vincenzo La Mura, Mauro Bernardi, Paolo Angeli","doi":"10.1016/j.jhep.2024.09.036","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.09.036","url":null,"abstract":"Professor Francesco Salerno was a brilliant man who dedicated his life to helping patients with advanced chronic liver diseases and who was internationally renowned for his studies on the pathophysiology of cirrhosis and its complications, as well as the management of patients with ascites, renal dysfunction and bacterial infections. He contributed to the foundation of key international groups such as the International Club of Ascites, the CLIF consortium, and the Baveno group.","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142588926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late use of Plasma Exchange in Acute Liver Failure: The Battle is Lost? 急性肝衰竭患者晚期使用血浆置换术:战斗已经失败?
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-06 DOI: 10.1016/j.jhep.2024.10.039
Valentin Coirier, Florent Artru, Christophe Camus

Section snippets

Declaration of Competing Interest

none

Financial disclosure

none

Author contributions

all authors contributed equally to the manuscript in terms of concept, writing, editing.
章节片段竞争利益声明无财务披露无作者贡献所有作者在构思、写作和编辑方面对稿件做出了同等贡献。
{"title":"Late use of Plasma Exchange in Acute Liver Failure: The Battle is Lost?","authors":"Valentin Coirier, Florent Artru, Christophe Camus","doi":"10.1016/j.jhep.2024.10.039","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.039","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Declaration of Competing Interest</h2>none</section></section><section><section><h2>Financial disclosure</h2>none</section></section><section><section><h2>Author contributions</h2>all authors contributed equally to the manuscript in terms of concept, writing, editing.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142588327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is there a safe limit for consumption of alcohol? 饮酒有安全限度吗?
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-11-01 DOI: 10.1016/j.jhep.2024.10.024
Jessica Ann Musto, Randall Brown, Michael Ronan Lucey
In order to understand and curb the harms related to alcohol, it will be necessary to think beyond patterns of use that meet criteria for a diagnosis of alcohol use disorder, or addiction. Current research suggests that regular daily alcohol use does not confer a health benefit, and for many persons, even relatively low consumption is associated with a health risk. Determining a safe limit for alcohol consumption is challenging both for the individual person and for society. We conclude that excessive drinking is always risky. We provide a list of circumstances, such as chronic illness, driving a vehicle, or pregnancy where persons should be advised to abstain from alcohol. We recognize the need to encourage less consumption of alcohol, particularly in young adults, and in older adults with co-morbid conditions particularly when taking multiple medications. Finally, we offer the modest proposal that, for persons without the contributing negative influences described above, consumption which adheres to one drink per session, with interspersed abstinent days, does not constitute a meaningful risk to health.
为了了解和遏制与酒精有关的危害,有必要超越符合酒精使用障碍或成瘾诊断标准的使用模式。目前的研究表明,每天定期饮酒并不会给健康带来好处,对许多人来说,即使相对较少的饮酒量也会带来健康风险。对个人和社会而言,确定一个安全的饮酒限度都具有挑战性。我们的结论是,过度饮酒总是有风险的。我们列举了一些应建议人们戒酒的情况,如慢性疾病、驾驶车辆或怀孕。我们认识到有必要鼓励减少饮酒,尤其是年轻人和患有并发症的老年人,特别是在服用多种药物的情况下。最后,我们提出一个适度的建议,即对于没有上述不良影响的人来说,每次只饮一杯酒,中间有几天不饮酒,并不会对健康构成严重威胁。
{"title":"Is there a safe limit for consumption of alcohol?","authors":"Jessica Ann Musto, Randall Brown, Michael Ronan Lucey","doi":"10.1016/j.jhep.2024.10.024","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.024","url":null,"abstract":"In order to understand and curb the harms related to alcohol, it will be necessary to think beyond patterns of use that meet criteria for a diagnosis of alcohol use disorder, or addiction. Current research suggests that regular daily alcohol use does not confer a health benefit, and for many persons, even relatively low consumption is associated with a health risk. Determining a safe limit for alcohol consumption is challenging both for the individual person and for society. We conclude that excessive drinking is always risky. We provide a list of circumstances, such as chronic illness, driving a vehicle, or pregnancy where persons should be advised to abstain from alcohol. We recognize the need to encourage less consumption of alcohol, particularly in young adults, and in older adults with co-morbid conditions particularly when taking multiple medications. Finally, we offer the modest proposal that, for persons without the contributing negative influences described above, consumption which adheres to one drink per session, with interspersed abstinent days, does not constitute a meaningful risk to health.","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142562215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Hepatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1